Rhumbline Advisers Sells 1,996 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
Rhumbline Advisers decreased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 200,836 shares of the biotechnology company’s stock after selling 1,996 shares during the period. […]
Rhumbline Advisers decreased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 200,836 shares of the biotechnology company’s stock after selling 1,996 shares during the period. […]
